Dimension Capital — Full Portfolio
30 tracked investments · listed companies and verified rows first
Monte Rosa develops molecular glue degrader (MGD) therapeutics using MGD chemistry, artificial intelligence, structural biology, and proteomics to target previously undruggable or inadequately drugged disease targets.
AI & Machine LearningBiotechDeep TechHealthtechBoston, US
Markus Warmuth(M.D., Chief Executive Officer)inSharon Townson(Ph.D., Chief Scientific Officer)inJohn Castle(Ph.D., Chief Data and Information Officer)inFilip Janku(M.D., Ph.D., Chief Medical Officer)inPhil Nickson(Ph.D., J.D., Chief Business and Legal Officer)inMagnus Walter(DPhil, Chief Technology Officer)in
Co-investorsAisling CapitalNew Enterprise Associates (NEA)Versant VenturesHBM PartnersAmzak HealthAvoro Capital Advisors+1 more
San Francisco, US
Todd Huffman(Executive Officer, Director)Megan Klimen(Executive Officer)
BoardJoshua Wolfe(Director)Matt Ocko(Director)inAdam Goulborn(Director)
Board seatAdam Goulburn· per SEC Form D · $14M raise · filed Jul 2016
Co-investorsComet LabsDCVC (Data Collective)Dolby Family VenturesLux CapitalOS Fund
Collaborative scholarly writing tool turned preprint archive, owned by Wiley since 2018.
New York, US
Nathan Jenkins(Executive Officer)Alberto Pepe(Executive Officer, Director)Matteo Cantiello(Director)
BoardDavid Teten(Director)Brian Cohen(Director)
Board seatAdam Goulburn· per SEC Form D · $1.5M raise · filed Jan 2016
Co-investorsFf Venture CapitalNew York Venture PartnersBloomberg BetaLux Capital
Professional drone racing league whose pilots fly identical custom-built FPV drones on 3D courses broadcast worldwide.
New York, US
Nicholas Horbaczewski(Executive Officer, Director)
Board seatAdam Goulburn· per SEC Form D · $50M raise · filed Jun 2019
Co-investorsCerity Partners VenturesChaifetz GroupLux CapitalRSE VenturesCRCM VenturesHearst Ventures
NewLimit develops epigenetic reprogramming medicines to extend healthspan and treat age-related diseases at the intersection of computer science and biotechnology.
AI & Machine LearningBiotechLongevitySouth San Francisco, US
Brian Armstrong(Co-founder, Board of Directors)inBlake Byers(Director)inJacob Kimmel(Director)inMichael Polansky(Executive Officer)
Board seatZavain Dar· per SEC Form D
Co-investorsS32Valor Equity Partners8VCAbstract Venturesage1Beyond Capital+8 more
Odyssey Therapeutics develops small molecule and protein therapeutics targeting upstream signaling nodes and innate immune system mechanisms to prevent pathological inflammation.
BiotechMedical DevicesCambridge, US
Gary D Glick(Executive Officer, Director)in
BoardJill Carroll(Director)inCarl Gordon(Director)inValerie Odegard(Director)Jeffrey Leiden(Director)Charles Baum(Director)in
Board seatNan Li· per SEC Form D
Co-investorsActivant CapitalBalderton CapitalCatalio Capital Management, LPForesite CapitalGlobal BioAccess FundGreatPoint Ventures+8 more
Pager Health provides a white-label care navigation platform that combines AI with clinicians to help members find, access, and stay engaged with healthcare.
AI & Machine LearningDigital HealthHealthtechNew York, US
Gaspard de Dreuzy(Executive Officer, Director)inPhillip Eytan(Executive Officer, Director)Oscar Salazar(Director)Philip Eytan(Executive Officer, Director, Promoter)Walter Jin(Chairman & CEO)inSandy Clarke(Chief Financial Officer)in
Board seatAdam Goulburn· per SEC Form D · $50M raise · filed Jun 2021
Co-investorsHealth Catalyst CapitalNew Enterprise Associates (NEA)Streamlined VenturesGoodwater CapitalLux CapitalMontage Ventures
Riskgaming creates immersive strategy simulation games where high-level decision-makers assume roles and navigate complex scenarios involving technology, business, and geopolitical challenges to explore alternative outcomes and inform real-world decisions.
BiotechHayward, US
Kegan Schouwenburg(Executive Officer, Director)Roger M. Perlmutter(Executive Officer, Director)in
BoardJoshua Wolfe(Director)inDror Berman(Director)James Tananbaum(Director)Leon Chen(Director)
Board seatAdam Goulburn· per SEC Form D · $525M raise · filed Jan 2022
Co-investorsBain Capital Life SciencesCisco InvestmentsForesite CapitalLux Capital
San Francisco, US
Shashank Samala(Cofounder)Jeffrey McAlvay(Executive Officer, Director)Jesse Koenig(Executive Officer)
Board seatZavain Dar· per SEC Form D · $20.7M raise · filed Aug 2017
Co-investorsGrit VenturesKeiretsu ForumLux CapitalPoint72 VenturesSQN Venture Partners, LLCUncork Capital+2 more
Variant Bio is a therapeutics company that uses human genomics to guide drug development, drawing on expertise across genetics, molecular biology, therapeutics, anthropology, and ethics.
AI & Machine LearningBiotechDigital HealthNew York, US
Kaja Wasik(Executive Officer, Director)inAndrew Farnum(Chief Executive Officer)inStephane Castel(Co-Founder, Chief Scientific & Technology Officer)inCraig Basson(Chief Medical Officer, President of R&D)inHolly Vance(Chief Operating Officer)in
BoardJulie Sunderland(Director)
Board seatAdam Goulburn· per SEC Form D · $31.5M raise · filed Oct 2019
Co-investorsAlta PartnersGeneral CatalystLux CapitalSoftBank Vision Fund
.png)
Achira builds molecular world models that blend geometric deep learning, physics, and quantum chemistry to advance drug discovery and materials design.
AI & Machine LearningBiotechDeep Tech
John Chodera(President / CEO)inTheofanis Karaletsos
BoardZavain Dar(Board)in
Co-investorsCompoundNVIDIAAmplify PartnersDIMENSIONNVentures
AllStripes was a health technology company that built a research platform for rare diseases, collecting and de-identifying patients' medical records to power rare disease research.
Digital HealthHealthtech
Nancy Yu(Founder)in
Co-investorsGaruda VenturesJAZZ Venture PartnersLux CapitalMaveronShasta VenturesSpark Capital
Aspect Biosystems develops bioprinted tissue therapeutics using a platform that combines AI-powered bioprinting, computational design tools, therapeutic cells, and biomaterials to create implantable allogeneic tissues.
AI & Machine LearningBiotechLongevity
Tamer Mohamed(Founder & CEO)inSam Wadsworth(Co-founder & Chief Scientific Officer)inSimon Beyer(Co-founder & Chief Technology Officer)inLeela Paris(Chief Technical Operations Officer)inMike Scott(Chief Development Officer)inRay Smith(Chief Financial Officer)in
Co-investorsAngel ForumCivilization Ventures Management, LlcInBC Investment Corp.JDRF T1D FundPage One VenturesPallasite Ventures+5 more
Automata provides lab automation and data management tools, enabling researchers and technicians to generate accurate data at scale through intuitive workflow creation.
Advanced ManufacturingAI & Machine LearningDeep TechHardwareHealthtechLegalTechRoboticsSaaSLondon, GB
Mostafa ElSayed(CEO and Co-Founder)inSuryansh Chandra(Co-Founder)
Co-investorsAir Street CapitalBlue Wire CapitalEntrepreneur FirstHCVCHummingbird VenturesIn-Q-Tel+9 more
Axi.om uses agentic intelligence and AI to predict, explain, and fix drug toxicity early in development by leveraging the largest experimental-to-clinical dataset of profiled molecules linked to human clinical outcomes.
AI & Machine LearningBiotechMedical Devices
Co-investorsAbstract VenturesAmplify PartnersCRV (Charles River Ventures)Inception Studio CapitalAtria Ventures
Chai Discovery builds a computer-aided design suite using artificial intelligence to design new molecules and drugs.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Joshua Meier(Founder & CEO)inJack Dent(Founder)in
Co-investorsAmplify PartnersAvenir Growth CapitalBain Capital VenturesBattery VenturesDCVC (Data Collective)General Catalyst+13 more
Convoke offers an AI platform that ingests and structures data from documents, scientific literature, SEC filings, and clinical data, and deploys custom agents to automate knowledge tasks and generate reports, manuscripts, and landscape analyses.
AI & Machine LearningBiotechEnterprise SoftwareHealthtechSaaS
Co-investorsAudaciousKleiner Perkins6 Dimensions CapitalACMEComma CapitalLux Capital+2 more
Clinical-stage biotech using AI and metabolomics to decode natural chemistry and discover small-molecule medicines.
Viswa Colluru, PhD(Founder)in
Co-investorsAir Street CapitalBoulder VenturesCatalio Capital Management, LPFPVHummingbird VenturesJAZZ Venture Partners+7 more
Fiveonefour builds tooling focused on agent experience (AX), helping developers ship software that AI agents can use effectively.
AI & Machine LearningDeveloper ToolsSaaSPortland, US
Timote Gelinas Delisle(Executive Officer, Director, Promoter)Chris Crane(Founder)inNicolas Joseph(Founder)in
Co-investorsFlybridge Capital PartnersVermilion Cliffs Ventures6 Dimensions CapitalRidge VenturesStage 2 Capital
Kaleidoscope provides a software platform for scientific R&D teams to track and communicate project data, manage complex research processes, and accelerate decision-making.
BiotechEnterprise SoftwareSaaSNew York City, US
Ewan Taylor(CSO and Co-founder)Geraldine Paulus(Co-founder, VP Operations)Brian Naughton(Co-founder and CTO)inDavid Yen(Founder)inBogdan Knezevic(Founder)in
Co-investorsAIN VenturesBurda Principal InvestmentsHAWKTAILHummingbird Ventures3x5 PartnersRally Ventures Management, Llc
Kimia is a therapeutics company developing new drugs through its ATLAS platform, working with partners in the pharmaceutical and biotechnology industries.
AI & Machine LearningBiotechDeep Tech
Stig Hansen(Founder)in
Co-investorsHorizons VenturesThe Column GroupAirTree VenturesBlackbird VenturesDIMENSIONSkip Capital
Lamin provides a lineage-native lakehouse platform for biological R&D that enables scientists to query, trace, and validate complex biological datasets across academia, biotech, and pharma.
AI & Machine LearningBiotechData & InfrastructureDeveloper ToolsEnterprise SoftwareHealthtechMunich, DE
Alex Wolf(Co-Founder & CEO)inSunny Sun(Founder)inFrederic Enard(Co-CTO & Founding Engineer)in
Co-investorsY Combinator
Modal provides a cloud platform that lets developers define compute, hardware, and application logic in Python and deploy to the cloud, with fast-booting containers and autoscaling GPUs.
AI & Machine LearningCloud ComputingDeveloper ToolsNew York, US
Erik Bernhardsson(Founder)inAkshat Bubna(Founder)in
Co-investorsAmplify PartnersLux CapitalRedpoint VenturesCreandumGeneral CatalystAbstraction Capital+9 more
Stately Bio develops stem cell-derived regenerative and cell therapies using a machine learning platform that measures cell identity, behavior, and maturation directly from live-cell, label-free imaging.
AI & Machine LearningBiotechMedical Devices
Frank Li(Founder & CEO)Christian Elabd, PhD(Head of Biology)
Co-investorsAIX VenturesFoothill VenturesMitsui Global InvestmentAxial VCBoxOne VenturesCaffeinated Capital+1 more
Tamarind provides a computational platform for protein and molecular engineering, offering AI and physics-based tools to design antibodies, peptides, enzymes, and small molecules.
AI & Machine LearningBiotechDeep TechEnterprise SoftwareSaaSSan Francisco, US
Deniz Kavi(Co-founder & CEO)inSherry Liu(Founder)in
Co-investorsTreeo VCY Combinator468 Capital6 Dimensions Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CareGuardianEnveda Therapeutics, Inc.Hometeam Technologies, Inc.Congruence TherapeuticsEarendil Labs
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.